Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

BACKGROUND: Atrial fibrillation (AF) is increasingly prevalent in chronic kidney disease (CKD) patients. The efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in AF and CKD patients remains unknown. This systematic review and meta-analysis will mainly assess net clinical be...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Nan-Nan, Zhang, Xue-Min, Le, Ke-Jia, Wei, An-Hua, Wu, Yue, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617430/
https://www.ncbi.nlm.nih.gov/pubmed/31261559
http://dx.doi.org/10.1097/MD.0000000000016194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617430/
https://www.ncbi.nlm.nih.gov/pubmed/31261559
http://dx.doi.org/10.1097/MD.0000000000016194

Ejemplares similares